Product details

In August 1999, Warwick Wilkinson, Chair of the National Competition Review of Pharmacy, was reading the submissions received by the review team in preparation for writing his interim report. When he read the joint submission from the Pharmacy Guild and Pharmaceutical Society, he realised he had to make a decision. The National Competition Policy Review of Pharmacy legislation was unusual in eliciting explicit public presentation of quantitative estimation of the benefits and costs of pharmacy ownership provisions. It is therefore a useful case for pursuing issues as to how evidence-based analysis influenced public decision-making.